Lv3
255 积分 2020-08-18 加入
Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics
26天前
已完结
Predicting the Long-Term Stability of Biologics with Short-Term Data
3个月前
已完结
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
7个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
8个月前
已完结
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
9个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
9个月前
已关闭
Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives
9个月前
已完结
Preclinical risk assessment strategy to mitigate the T-cell dependent immunogenicity of protein biotherapeutics: State of the art, challenges and future perspectives
1年前
已完结
Nonclinical immunogenicity risk assessment of therapeutic proteins
1年前
已完结
A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5
1年前
已完结
皖公网安备34019202002308
